Literature DB >> 3341233

Propafenone for paroxysmal atrial fibrillation.

S C Hammill1, D L Wood, B J Gersh, M J Osborn, D R Holmes.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1988        PMID： 3341233     DOI： 10.1016/0002-9149(88)90312-8

Source DB:  PubMed          Journal:  Am J Cardiol        ISSN： 0002-9149            Impact factor:   2.778


× No keyword cloud information.
  7 in total

1.  Is there a synergic effect of propafenone associated with atrial overdrive pacing for atrial arrhythmia prevention? A randomised crossover study.

Authors:  S Garrigue; S S Barold; S Cazeau; M Hocini; P Jais; M Haissaguerre; J Clementy
Journal:  Heart       Date:  2000-02       Impact factor: 5.994

2.  The drug treatment of atrial fibrillation.

Authors:  K S Channer
Journal:  Br J Clin Pharmacol       Date:  1991-09       Impact factor: 4.335

Review 3.  Propafenone. A reappraisal of its pharmacology, pharmacokinetics and therapeutic use in cardiac arrhythmias.

Authors:  H M Bryson; K J Palmer; H D Langtry; A Fitton
Journal:  Drugs       Date:  1993-01       Impact factor: 9.546

4.  Propafenone versus disopyramide for maintenance of sinus rhythm after electrical cardioversion of chronic atrial fibrillation: a randomized, double-blind study. PRODIS Study Group.

Authors:  H J Crijns; A T Gosselink; K I Lie
Journal:  Cardiovasc Drugs Ther       Date:  1996-05       Impact factor: 3.727

5.  Time of occurrence, duration, and ventricular rate of paroxysmal atrial fibrillation: the effect of digoxin.

Authors:  J M Rawles; M J Metcalfe; K Jennings
Journal:  Br Heart J       Date:  1990-04

Review 6.  Propafenone in the treatment of cardiac arrhythmias. A risk-benefit appraisal.

Authors:  A Capucci; G Boriani
Journal:  Drug Saf       Date:  1995-01       Impact factor: 5.606

7.  Antiarrhythmics for maintaining sinus rhythm after cardioversion of atrial fibrillation.

Authors:  Lucie Valembois; Etienne Audureau; Andrea Takeda; Witold Jarzebowski; Joël Belmin; Carmelo Lafuente-Lafuente
Journal:  Cochrane Database Syst Rev       Date:  2019-09-04
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.